Warning! GuruFocus detected
1 Severe warning sign
with ALLR.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Allarity Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US0167443029
Description
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.81 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | -71.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 78.74 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.48 | |||||
| 9-Day RSI | 62.32 | |||||
| 14-Day RSI | 57.55 | |||||
| 3-1 Month Momentum % | -30.54 | |||||
| 6-1 Month Momentum % | -69.21 | |||||
| 12-1 Month Momentum % | -99.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 2.75 | |||||
| Cash Ratio | 2.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -741.38 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -465 | |||||
| ROA % | -105.57 | |||||
| ROIC % | -126.1 | |||||
| 3-Year ROIIC % | 45.81 | |||||
| ROC (Joel Greenblatt) % | -95177.08 | |||||
| ROCE % | -396.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.24 | |||||
| Price-to-Tangible-Book | 0.24 | |||||
| EV-to-EBIT | 0.67 | |||||
| EV-to-EBITDA | 0.67 | |||||
| EV-to-FCF | 0.8 | |||||
| Price-to-Net-Current-Asset-Value | 0.24 | |||||
| Price-to-Net-Cash | 0.28 | |||||
| Earnings Yield (Greenblatt) % | 149.25 | |||||
| FCF Yield % | -321.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ALLR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Allarity Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -588.833 | ||
| Beta | 2.91 | ||
| 3-Year Sharpe Ratio | -0.1 | ||
| 3-Year Sortino Ratio | -0.38 | ||
| Volatility % | 95.3 | ||
| 14-Day RSI | 57.55 | ||
| 14-Day ATR ($) | 0.140563 | ||
| 20-Day SMA ($) | 0.963225 | ||
| 12-1 Month Momentum % | -99.62 | ||
| 52-Week Range ($) | 0.6775 - 199.619996 | ||
| Shares Outstanding (Mil) | 4.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Allarity Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Allarity Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Allarity Therapeutics Inc Frequently Asked Questions
What is Allarity Therapeutics Inc(ALLR)'s stock price today?
The current price of ALLR is $1.11. The 52 week high of ALLR is $199.62 and 52 week low is $0.68.
When is next earnings date of Allarity Therapeutics Inc(ALLR)?
The next earnings date of Allarity Therapeutics Inc(ALLR) is 2025-05-10 Est..
Does Allarity Therapeutics Inc(ALLR) pay dividends? If so, how much?
Allarity Therapeutics Inc(ALLR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers